WebChédiak–Higashi syndrome [1] ( CHS) is a rare autosomal recessive disorder that arises from a mutation of a lysosomal trafficking regulator protein, [2] which leads to a decrease in phagocytosis. The decrease in phagocytosis results in recurrent pyogenic infections, albinism, and peripheral neuropathy . WebA mysterious condition can make marijuana users violently ill, and it reveals a hidden downside to the drug's growing popularity. Erin Brodwin. Alice Moon, who has cannabinoid hyperemesis syndrome ...
Cannabinoid Hyperemesis Syndrome (CHS) Is Real, But Genetic …
WebSince 1988, the CHS has aimed to identify risk factors related to the onset of coronary heart disease and stroke in adults aged 65 or older. Nearly 6,000 men and women were recruited from four communities for the study. The CHS characterized a previously unrecognized form of heart failure that is especially common in older adults. WebAug 27, 2024 · CHS is a disease that causes marijuana users to experience high sensitivity to cannabinoid compounds —especially THC. An average of one Cannabinoid Hyperemesis Syndrome case is diagnosed in a month. … dr rizvia khan
What is Chediak-Higashi Syndrome? - news-medical.net
WebCannabis hyperemesis syndrome (CHS) is a condition caused by long-term cannabis use. People who have CHS experience recurring episodes of nausea, vomiting, dehydration … WebCentral hypoventilation syndrome. Central hypoventilation syndrome ( CHS) is a sleep-related breathing disorder that causes ineffective breathing, apnea, or respiratory arrest during sleep (and during wakefulness in severe cases). CHS can either be congenital (CCHS) or acquired (ACHS) later in life. The condition can be fatal if untreated. WebEffective Treatments for CHS. The most effective and safe treatment for cannabinoid hyperemesis syndrome is to stop using cannabis entirely. The journal Current Drug Abuse Review publishes that the two main … rationalwiki north korea